ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+12.72%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.18B
AUM Growth
+$2.18B
(-16%)
Cap. Flow
-$366M
Cap. Flow
% of AUM
-16.82%
Top 10 Holdings %
Top 10 Hldgs %
69.39%
Holding
52
New
9
Increased
7
Reduced
15
Closed
7
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$65.8M |
| 2 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$20.6M |
| 3 |
Xenon Pharmaceuticals
XENE
|
$15.4M |
| 4 |
Establishment Labs
ESTA
|
$11.4M |
| 5 |
ACER
Acer Therapeutics Inc. Common Stock (DE)
ACER
|
$8.64M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$75.7M |
| 2 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$71.7M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$69M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$54.4M |
| 5 |
Pacira BioSciences
PCRX
|
$51.5M |
Sector Composition
| 1 | Healthcare | 82.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $369M | 16.94% | 17,714,461 | – | – |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $226M | 10.38% | 4,798,101 | – | – |
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $152M | 7% | 943,500 -15,428 | -2% | -$2.49M |
|
4
Ascendis Pharma
ASND
$11.8B
| $139M | 6.39% | 1,963,336 -100,000 | -5% | -$7.09M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $133M | 6.09% | 1,368,103 -254,667 | -16% | -$24.7M |
|
6
Amicus Therapeutics
FOLD
$2.34B
| $113M | 5.18% | 9,333,132 -36,018 | -0.4% | -$435K |
|
7
Madrigal Pharmaceuticals
MDGL
$9.76B
| $99.1M | 4.55% | 463,000 -26,536 | -5% | -$5.68M |
|
8
Iovance Biotherapeutics
IOVA
$807M
| $97.5M | 4.48% | 8,662,720 +485,000 | +6% | +$5.46M |
|
|
ECYT
9
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $94.2M | 4.32% | 5,301,718 -393,482 | -7% | -$6.99M |
|
|
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $87.3M | 4.01% | 4,460,426 -1,133,257 | -20% | -$22.2M |
|
|
ZGNX
11
DELISTED
Zogenix, Inc.
ZGNX
| $72.3M | 3.32% | 1,457,913 -45,400 | -3% | -$2.25M |
|
|
AMRN
12
Amarin Corp
AMRN
$311M
| $65.8M | 3.02% | +4,045,000 | New | +$65.8M |
|
13
argenx
ARGX
$43.6B
| $57.3M | 2.63% | 755,415 -26,638 | -3% | -$2.02M |
|
|
TCDA
14
DELISTED
Tricida, Inc. Common Stock
TCDA
| $54.1M | 2.49% | 1,771,500 +675,736 | +62% | +$20.6M |
|
15
Puma Biotechnology
PBYI
$254M
| $52.8M | 2.42% | 1,150,685 +116,310 | +11% | +$5.33M |
|
16
Assembly Biosciences
ASMB
$190M
| $38.9M | 1.79% | 1,048,427 +85,000 | +9% | +$3.16M |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $33.7M | 1.55% | 1,146,636 +200 | +0% | +$5.87K |
|
|
18
PTC Therapeutics
PTCT
$3.92B
| $32.1M | 1.48% | 684,000 -1,610,877 | -70% | -$75.7M |
|
|
19
Xenon Pharmaceuticals
XENE
$2.98B
| $31.2M | 1.43% | 2,367,218 +1,165,100 | +97% | +$15.4M |
|
20
TG Therapeutics
TGTX
$4.65B
| $23.5M | 1.08% | 4,200,031 -750,000 | -15% | -$4.2M |
|
|
TLGT
21
DELISTED
Teligent, Inc
TLGT
| $20.9M | 0.96% | 5,299,431 | – | – |
|
|
22
Pacira BioSciences
PCRX
$1.2B
| $20.3M | 0.93% | 413,196 -1,047,414 | -72% | -$51.5M |
|
23
Catalyst Pharmaceutical
CPRX
$2.52B
| $17M | 0.78% | 4,497,042 | – | – |
|
24
Arrowhead Research
ARWR
$3.05B
| $16.3M | 0.75% | 849,899 +399,899 | +89% | +$7.67M |
|
|
BDSI
25
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $15.2M | 0.7% | 5,437,779 | – | – |
|